MDS Podcast
By International Parkinson and Movement Disorder Society
Listen to a podcast, please open Podcast Republic app. Available on Google Play Store and Apple App Store.
Category: Science
Open in Apple Podcasts
Open RSS feed
Open Website
Rate for this podcast
Subscribers: 13
Reviews: 0
Episodes: 161
Description
Stay up to date on novel, clinically-relevant research findings in Parkinson's disease and other movement disorders. Each episode of the International Parkinson and Movement Disorder Society podcast discusses a relevant development in the field, including highlighted journal articles and interviews with the authors.
| Episode | Date |
|---|---|
|
Special Series: Approach to patients with genetic choreas
|
Apr 22, 2024 |
|
Concomitant pathologies and their clinical impact in multiple system atrophy
|
Apr 15, 2024 |
|
Special Series: Phenomenology of Chorea
|
Apr 08, 2024 |
|
Special Issue - Biomarker Updates: The Parkinson's disease pandemic
|
Apr 01, 2024 |
|
Special Issue - Biomarker Updates: The immune system in Parkinson’s disease
|
Apr 01, 2024 |
|
Special Issue - Biomarker Updates: Ongoing pharmacological developments in Parkinson’s disease and related disorders
|
Apr 01, 2024 |
|
Special Issue - Biomarker Updates: A conversation on biomarkers and diagnostics of Parkinson's disease and related disorders
|
Apr 01, 2024 |
|
Special Episode: The wisdom of our mentors: clinical pearls in movement disorders
|
Mar 25, 2024 |
|
Hot Topic: Focused Ultrasound in Movement Disorders - Blood-Brain Barrier Opening
|
Mar 18, 2024 |
|
Pallidotomy for Focal and Hemidystonia
|
Mar 11, 2024 |
|
Hot Topic: Focused Ultrasound in Movement Disorders - Neuromodulation
|
Mar 04, 2024 |
|
Erythrocytic α-synuclein and spreading pathology in Parkinson’s disease
|
Feb 26, 2024 |
|
Mortality in Parkinson's disease: findings from a nationwide study from Finland
|
Feb 12, 2024 |
|
Local fields potentials can help DBS programming in Parkinson's disease in clinical practice
|
Jan 29, 2024 |
|
Deep brain stimulation for GBA-related Parkinson's disease: is it a reasonable option?
|
Jan 15, 2024 |
|
Family history and genetic Alzheimer's risk and ties to Parkinson's disease
|
Jan 02, 2024 |
|
Unravelling the progression of tremor in Parkinson's disease
|
Dec 18, 2023 |
|
Using EEG to Identify Parkinson's Subtypes
|
Dec 04, 2023 |
|
Hot Topic: Tissue-based biomarkers in Parkinson's disease
|
Nov 20, 2023 |
|
Expanded and Independent Spanish Validation of the MDS Non-Motor Rating Scale
|
Nov 06, 2023 |
|
Hot topic: GP2 and underrepresented populations
|
Oct 23, 2023 |
|
Task-specific brain oscillatory activity in laryngeal dystonia
|
Oct 09, 2023 |
|
MDJ Review Article of the Year Award: How does DBS change the course of Parkinson's?
|
Oct 02, 2023 |
|
MDCP Review Article of the Year: Alpha-Synuclein Seed Amplification Assays in CSF
|
Oct 02, 2023 |
|
The Role of Levodopa Challenge in Predicting the Outcome of STN DBS
|
Sep 25, 2023 |
|
Updates in Tremor Treatments | Congress 2023
|
Sep 18, 2023 |
|
Updates in MDS Education | Congress 2023
|
Sep 18, 2023 |
|
Updates in Gene Therapy | Congress 2023
|
Sep 18, 2023 |
|
The Basic Science Perspective on the Role of Alpha-Synuclein | Congress 2023
|
Sep 18, 2023 |
|
The Basic Science Perspective on Future Therapeutic Targets | Congress 2023
|
Sep 18, 2023 |
|
Sleep and Cognitive Decline | Congress 2023
|
Sep 18, 2023 |
|
Presidential Perspective | Congress 2023
|
Sep 18, 2023 |
|
Highlights in Tic and Stereotypies | Congress 2023
|
Sep 18, 2023 |
|
Highlights in Progressive Supranuclear Palsy Research | Congress 2023
|
Sep 18, 2023 |
|
Highlights in Multiple System Atrophy Research | Congress 2023
|
Sep 18, 2023 |
|
Heterogeneity of Parkinson's Disease | Congress 2023
|
Sep 18, 2023 |
|
Advancements in Dystonia Treatments | Congress 2023
|
Sep 18, 2023 |
|
New loci for Parkinson disease is identified in Latin America cohorts
|
Sep 04, 2023 |
|
Award Article: Long duration levodopa response and neuroplasticity in Parkinson’s disease
|
Aug 31, 2023 |
|
Award Article: Have we forgotten what tics are?
|
Aug 31, 2023 |
|
Perry Disease
|
Aug 04, 2023 |
|
Pleiotropy in Parkinson´s disease and Cancer: Is there an association between these entities?
|
Jul 24, 2023 |
|
Parkin Maintains Robust Pacemaking in Human iPSC-derived A9 Dopaminergic Neurons
|
Jul 07, 2023 |
|
Getting involved in the MDS: a fruitful relationship
|
Jun 26, 2023 |
|
A cross-sectional study of PPMI participants using alpha-synuclein seed amplification as a biomarker
|
Jun 12, 2023 |
|
Inflammation is an early feature of Parkinson's disease
|
May 29, 2023 |
|
Diagnosis of Late-Onset Wilson's Disease
|
May 15, 2023 |
|
International Parkinson and Movement Disorder Society Mission and Structure
|
May 08, 2023 |
|
Deep brain stimulation in Parkinson's disease with cognitive impairment: real-world evidence
|
May 01, 2023 |
|
History of Movement Disorders: The Finding of Alpha-Synuclein and Lewy Bodies
|
Apr 24, 2023 |
|
Hot topic: The gut microbiome in Parkinson's
|
Apr 17, 2023 |
|
Pathological Validation of 2022 MSA Criteria
|
Apr 10, 2023 |
|
Walking through the falls: understanding gait with wearable sensors in Parkinson's disease
|
Mar 27, 2023 |
|
Targeting alpha synuclein in early Parkinson's disease. Clinical trials and future perspectives
|
Mar 20, 2023 |
|
Current and future approaches to treatment of dystonia
|
Mar 13, 2023 |
|
Unraveling the neural routes of dystonia
|
Mar 06, 2023 |
|
Machine learning for drug repurposing: A novel approach to find new treatments for Parkinson's disease
|
Feb 27, 2023 |
|
Genetic landscape of dystonia
|
Feb 20, 2023 |
|
Clozapine in Parkinson's disease: Why, when and how?
|
Feb 13, 2023 |
|
Beyond “torsion": non-motor features of dystonia
|
Feb 06, 2023 |
|
Off-State Dyskinesias after GDNF Infusion in Parkinson's Disease
|
Jan 30, 2023 |
|
Pearls on diagnosis and phenomenology
|
Jan 23, 2023 |
|
Idiopathic Normal Pressure Hydrocephalus: Critical Review of Objective Findings
|
Jan 16, 2023 |
|
History of Movement Disorders: Huntington's Disease in Venezuela
|
Jan 09, 2023 |
|
Striatal Blood Brain Barrier Opening in Parkinson's Dementia
|
Dec 20, 2022 |
|
Deep brain stimulation for Parkinson's disease dementia: are we there yet?
|
Dec 12, 2022 |
|
The Genetic Landscape of Complex Childhood-Onset Hyperkinetic Movement Disorders
|
Nov 28, 2022 |
|
Can dogs diagnose Parkinson's disease?
|
Nov 14, 2022 |
|
Nosology and Cut-Off Values for Axial Postural Abnormalities in Parkinsonism
|
Oct 31, 2022 |
|
COVID-19 and the Risk of Parkinsonism
|
Oct 17, 2022 |
|
New Technology in Movement Disorders | Congress 2022
|
Oct 01, 2022 |
|
Updates on Multiple System Atrophy Research | Congress 2022
|
Oct 01, 2022 |
|
Updates on Dystonia | Congress 2022
|
Oct 01, 2022 |
|
Updates of Functional Movement Disorders | Congress 2022
|
Oct 01, 2022 |
|
Highlights on Tremor Disorders | Congress 2022
|
Oct 01, 2022 |
|
Highlights on Tic Disorders - Congress 2022
|
Oct 01, 2022 |
|
Highlights on Parkinson’s Disease | Congress 2022
|
Oct 01, 2022 |
|
Highlights in Neuroimaging | Congress 2022
|
Oct 01, 2022 |
|
Highlights in Movement Disorder Education | Congress 2022
|
Oct 01, 2022 |
|
Genetic Highlights in Movement Disorders | Congress 2022
|
Oct 01, 2022 |
|
Basic Science Updates in Movement Disorders | Congress 2022
|
Oct 01, 2022 |
|
An Interview with MDS President Francisco Cardoso | Congress 2022
|
Oct 01, 2022 |
|
Advances in Supranuclear Palsy Research | Congress 2022
|
Oct 01, 2022 |
|
Award Replay: MDS Criteria for the diagnosis of Multiple System Atrophy: New features and implications
|
Sep 17, 2022 |
|
Award Article: A Multi-Step Model of Parkinson's Disease Pathogenesis
|
Sep 17, 2022 |
|
Parkinson's disease and type 2 diabetes: Clinical impact and therapeutic implications
|
Sep 05, 2022 |
|
Implanted system for orthostatic hypotension in multiple-system atrophy
|
Aug 22, 2022 |
|
Measuring gait through brain metabolism in Parkinson's disease: How it can help understanding and treating gait disorders
|
Aug 08, 2022 |
|
Peer review: Past, present and future
|
Jul 25, 2022 |
|
MDS Criteria for the diagnosis of Multiple System Atrophy: New features and implications
|
Jul 18, 2022 |
|
Parkinson's disease medications during hospitalization
|
Jun 30, 2022 |
|
How not to conduct a peer review: Fatal, avoidable errors.
|
Jun 27, 2022 |
|
Update from the Synuclein Meeting 2022
|
Jun 20, 2022 |
|
The Ethics of Peer Review
|
Jun 13, 2022 |
|
Pesticide exposure and dream-enacting behavior
|
Jun 06, 2022 |
|
The role of young members in the peer review process
|
May 30, 2022 |
|
Unmet needs of women with Parkinson's disease: Gaps and controversies
|
May 23, 2022 |
|
Approach to reviewing a review article
|
May 16, 2022 |
|
Rasagiline in PD: Does it change disease progression? And how do we measure it?
|
May 09, 2022 |
|
How to review an original scientific article
|
May 02, 2022 |
|
Infectious agents as drivers of synucleinopathies?
|
Apr 25, 2022 |
|
Reviewing case reports and clinical series
|
Apr 18, 2022 |
|
Does glucocerebrosidase activity correlate with disease risk or phenotype severity in Parkinson's disease?
|
Apr 11, 2022 |
|
What are journal editors looking for in a good review?
|
Apr 04, 2022 |
|
When to accept or decline an invitation to review
|
Mar 21, 2022 |
|
Bilateral focused ultrasound thalamotomy for essential tremor, is it safe?
|
Mar 14, 2022 |
|
Overview and core components of the peer review process
|
Mar 07, 2022 |
|
Neuropsychiatric features of punding and hobbyism in Parkinson's disease
|
Feb 15, 2022 |
|
Approach to neuroimaging in Parkinsonisms
|
Jan 17, 2022 |
|
Tau imaging for the study of corticobasal syndrome: The first steps of in vivo neuropathology
|
Dec 13, 2021 |
|
The most impactful paper related to movement disorders therapy in the 20th century
|
Oct 18, 2021 |
|
Swim for Parkinson: Swimming together to improve together
|
Oct 18, 2021 |
|
Perampanel may reduce alpha-synuclein transmission in Parkinson's disease. A possible therapeutic target?
|
Oct 18, 2021 |
|
Variability of movement disorders: The influence of sensation
|
Oct 18, 2021 |
|
An interview with Claudia Trenkwalder | Congress 2021
|
Sep 30, 2021 |
|
Blinded RT-QuIC analysis of alpha-synuclein biomarker in skin tissue from Parkinson's disease patients
|
Sep 01, 2021 |
|
TikTok tics
|
Aug 01, 2021 |
|
Cognitive and visuospatial abilities in dystonia
|
Jun 01, 2021 |
|
Autophagy in levodopa-induced dyskinesia: A new potential therapeutic target
|
May 01, 2021 |
|
Electroconvulsive therapy in movement disorders
|
Apr 01, 2021 |
|
Acetylcholine nuclei atrophy predicts gait changes in Parkinson's disease
|
Mar 01, 2021 |
|
Anxiety in parkinson's disease and its correlates in mri-based functional connectivity
|
Feb 01, 2021 |
|
Parkinsonian syndromes and Parkinson's subtypes: Will a single neuroimaging modality ever be enough?
|
Feb 01, 2021 |
|
Scar dancing syndrome
|
Jan 09, 2021 |
|
Neuroinflammation in Parkinson's disease
|
Jan 04, 2021 |
|
Neurofilament light chain in Parkinson's disease
|
Nov 20, 2020 |
|
Anti-inflammatory drugs use impacts the risk of developing PD in LRRK2 mutation carriers
|
Nov 09, 2020 |
|
The impact of COVID-19 on scientific research activities
|
Nov 06, 2020 |
|
Value of invivosynuclein deposits in Parkinson's disease - Asystematic review and metaanalysis
|
Oct 14, 2020 |
|
Randomized controlled trial of exercise on objective and subjective sleep in Parkinson's disease
|
Oct 14, 2020 |
|
Deep brain stimulation for Parkinson, beyond motor improvement: Social and occupational outcomes
|
Sep 22, 2020 |
|
Interview with Dr. Jon Stoessl on Preprints in the COVID-Era
|
Sep 20, 2020 |
|
Late-stage Parkinsonism: Do we know enough?
|
Jul 08, 2020 |
|
Interview with the president on the MDS activities during the COVID crisis
|
May 26, 2020 |
|
Practicing medicine in time of pandemic and future of Movement Disorders medical practice
|
May 26, 2020 |
|
How to manage Parkinson's disease and related disorders, and is there a link between COVID and PD?
|
May 18, 2020 |
|
Antibiotics and Parkinson's disease
|
Mar 31, 2020 |
|
Integrated therapy for functional movement disorders
|
Feb 21, 2020 |
|
Fine tuning DBS in Parkinson's disease. How much can we improve?
|
Feb 07, 2020 |
|
White matter changes in Huntington's disease
|
Jan 20, 2020 |
|
Parkinsonian syndromes and Parkinson's subtypes: Will a single neuroimaging modality ever be enough?
|
Jan 01, 2020 |
|
Parkinson's disease and Lewy body disorders | Congress 2019
|
Nov 06, 2019 |
|
New technologies in movement disorders | Congress 2019
|
Nov 06, 2019 |
|
Tremor | Congress 2019
|
Nov 06, 2019 |
|
Tic disorders and Tourette syndrome | Congress 2019
|
Nov 06, 2019 |
|
Atypical Parkinsonisms | Congress 2019
|
Nov 06, 2019 |
|
The treatment of upper limb tremor with botulinum toxin: An individualized approach
|
Nov 01, 2019 |
|
Neuroimaging in movement disorders | Congress 2019
|
Oct 24, 2019 |
|
Dystonia | Congress 2019
|
Oct 24, 2019 |
|
Huntington's disease | Congress 2019
|
Oct 23, 2019 |
|
Education at the MDS | Congress 2019
|
Oct 18, 2019 |
|
Introduction and functional movement disorders | Congress 2019
|
Oct 18, 2019 |
|
Definition and characteristics of early onset PSP: A different disease?
|
Oct 14, 2019 |
|
MDS PSP criteria in practice: From clinical phenotyping to pathological diagnosis
|
Aug 30, 2019 |
|
Iron imaging of substantia nigra in Parkinson's disease: A possible biomarker?
|
Aug 06, 2019 |
|
Patient vs. care partner assessment of cognitive disability in Parkinson's: Who's more accurate?
|
Jun 28, 2019 |
|
Long-term outcomes of focused ultrasound in essential tremor
|
Jun 06, 2019 |
|
When should dopaminergic treatment be initiated in Parkinson's disease?
|
Apr 30, 2019 |
|
Advanced therapies for Parkinson's disease: Are they all the same?
|
Mar 22, 2019 |
|
Is benign hereditary chorea really benign?
|
Feb 20, 2019 |
|
The Mediterranean diet in Parkinson's disease
|
Feb 11, 2019 |